nitrites has been researched along with Peripheral Vascular Diseases in 20 studies
Nitrites: Salts of nitrous acid or compounds containing the group NO2-. The inorganic nitrites of the type MNO2 (where M=metal) are all insoluble, except the alkali nitrites. The organic nitrites may be isomeric, but not identical with the corresponding nitro compounds. (Grant & Hackh's Chemical Dictionary, 5th ed)
Peripheral Vascular Diseases: Pathological processes involving any one of the BLOOD VESSELS in the vasculature outside the HEART.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We explored the efficacy of intravenous therapy with propionyl L-carnitine in patients with both peripheral arterial disease (PAD) and chronic renal insufficiency requiring haemodialysis." | 5.12 | A randomised, controlled clinical trial evaluating changes in therapeutic efficacy and oxidative parameters after treatment with propionyl L-carnitine in patients with peripheral arterial disease requiring haemodialysis. ( Celotta, G; Di Pino, L; Fallico, R; Fatuzzo, P; Ferrante, M; Massimiliano, A; Neri, S; Oliveri Conti, G; Pennisi, G; Rapisarda, F; Signorelli, SS, 2006) |
| "Dipyridamole treatment quickly restored ischaemic hindlimb blood flow, increased vascular density and cell proliferation, and enhanced collateral artery perfusion compared with control treatments." | 1.36 | Dipyridamole enhances ischaemia-induced arteriogenesis through an endocrine nitrite/nitric oxide-dependent pathway. ( Branch, B; Hood, J; Illum, S; Kevil, CG; Pardue, S; Patel, RP; Pattillo, CB; Teng, X; Thoma, S; Venkatesh, PK, 2010) |
| " Our data support the effects of statins in vivo that have been demonstrated on the endothelium ex vivo, suggesting a beneficial effect by acting on the initial processes that trigger the disease, reducing oxidative stress (increase in the bioavailability of nitric oxide as peroxynitrite levels decrease) and curtailing the inflammatory processes which perpetuate the disease." | 1.35 | In vivo confirmation of the role of statins in reducing nitric oxide and C-reactive protein levels in peripheral arterial disease. ( Aguilar, EM; Casariego, CV; García, FA; González, AF; Miralles, Jde H; Moreno, SB, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (45.00) | 18.7374 |
| 1990's | 2 (10.00) | 18.2507 |
| 2000's | 7 (35.00) | 29.6817 |
| 2010's | 2 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aguilar, EM | 1 |
| Miralles, Jde H | 1 |
| González, AF | 1 |
| Casariego, CV | 1 |
| Moreno, SB | 1 |
| García, FA | 1 |
| Allen, JD | 2 |
| Miller, EM | 1 |
| Schwark, E | 1 |
| Robbins, JL | 1 |
| Duscha, BD | 1 |
| Annex, BH | 1 |
| de Haro Miralles, J | 1 |
| Martínez-Aguilar, E | 1 |
| Florez, A | 1 |
| Varela, C | 1 |
| Bleda, S | 1 |
| Acin, F | 1 |
| Venkatesh, PK | 1 |
| Pattillo, CB | 1 |
| Branch, B | 1 |
| Hood, J | 1 |
| Thoma, S | 1 |
| Illum, S | 1 |
| Pardue, S | 1 |
| Teng, X | 1 |
| Patel, RP | 1 |
| Kevil, CG | 2 |
| Giordano, T | 1 |
| MARCHE, J | 1 |
| KRAUCHER, GK | 1 |
| HUEBER, EF | 1 |
| THALER, H | 1 |
| WICK, E | 1 |
| POLETTI, RA | 1 |
| SAMUELS, SS | 2 |
| DE LA PIERRE, M | 1 |
| BARBERA, G | 1 |
| COSTA, P | 1 |
| ABRAMSON, DI | 1 |
| KOLLMANN, HJ | 1 |
| de Berrazueta, JR | 1 |
| Sampedro, I | 1 |
| Garcia-Unzueta, MT | 1 |
| Llorca, J | 1 |
| Bustamante, M | 1 |
| Amado, JA | 1 |
| PADERNACHT, ED | 1 |
| Yamada, K | 1 |
| Suzuki, E | 1 |
| Nakaki, T | 1 |
| Watanabe, S | 1 |
| Kanba, S | 1 |
| Signorelli, SS | 1 |
| Fatuzzo, P | 1 |
| Rapisarda, F | 1 |
| Neri, S | 1 |
| Ferrante, M | 1 |
| Oliveri Conti, G | 1 |
| Fallico, R | 1 |
| Di Pino, L | 1 |
| Pennisi, G | 1 |
| Celotta, G | 1 |
| Massimiliano, A | 1 |
| Loffredo, L | 1 |
| Marcoccia, A | 1 |
| Pignatelli, P | 1 |
| Andreozzi, P | 1 |
| Borgia, MC | 1 |
| Cangemi, R | 1 |
| Chiarotti, F | 1 |
| Violi, F | 1 |
| Arosio, E | 1 |
| Cuzzolin, L | 1 |
| De Marchi, S | 1 |
| Minuz, P | 1 |
| Degan, M | 1 |
| Crivellente, F | 1 |
| Zannoni, M | 1 |
| Benoni, G | 1 |
| Ferlito, S | 1 |
| Gallina, M | 1 |
| Catassi, S | 1 |
| Bisicchia, A | 1 |
| Di Salvo, MM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Randomized, Placebo Controlled, Pilot Trial of Statin Use in Burn Patients[NCT00978419] | Phase 2 | 40 participants (Actual) | Interventional | 2010-03-31 | Completed | ||
| Effects of Trehalose and a Mix of Polyphenols on Endothelial Function, Oxidative Stress, Platelet Function and Autophagy in Vasculopathic Patients[NCT04061070] | 80 participants (Actual) | Interventional | 2019-12-12 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for nitrites and Peripheral Vascular Diseases
| Article | Year |
|---|---|
Nitrite and nitric oxide metabolism in peripheral artery disease.
Topics: Animals; Humans; Hypoxia; Nitric Oxide; Nitrites; Peripheral Vascular Diseases | 2012 |
5 trials available for nitrites and Peripheral Vascular Diseases
| Article | Year |
|---|---|
Effect of transdermal nitroglycerin on inflammatory mediators in patients with peripheral atherosclerotic vascular disease.
Topics: Administration, Cutaneous; Adult; Aged; Anti-Inflammatory Agents; Arteriosclerosis; Biomarkers; C-Re | 2003 |
Aconiti tuber increases plasma nitrite and nitrate levels in humans.
Topics: Aconitum; Adult; Aged; Chromatography, High Pressure Liquid; Drugs, Chinese Herbal; Female; Humans; | 2005 |
A randomised, controlled clinical trial evaluating changes in therapeutic efficacy and oxidative parameters after treatment with propionyl L-carnitine in patients with peripheral arterial disease requiring haemodialysis.
Topics: Aged; Aldehydes; Carnitine; Double-Blind Method; Humans; Malondialdehyde; Middle Aged; Nitrates; Nit | 2006 |
Oxidative-stress-mediated arterial dysfunction in patients with peripheral arterial disease.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antioxidants; Bio | 2007 |
Increased endogenous nitric oxide production induced by physical exercise in peripheral arterial occlusive disease patients.
Topics: Aged; Arterial Occlusive Diseases; Cell Adhesion; Exercise Therapy; Humans; Iloprost; Infusions, Int | 1999 |
14 other studies available for nitrites and Peripheral Vascular Diseases
| Article | Year |
|---|---|
In vivo confirmation of the role of statins in reducing nitric oxide and C-reactive protein levels in peripheral arterial disease.
Topics: Aged; Aged, 80 and over; Atorvastatin; C-Reactive Protein; Cholesterol; Female; Heptanoic Acids; Hum | 2009 |
Plasma nitrite response and arterial reactivity differentiate vascular health and performance.
Topics: Aged; Blood Flow Velocity; Brachial Artery; Endothelium, Vascular; Forearm; Humans; Middle Aged; Nit | 2009 |
Nitric oxide: link between endothelial dysfunction and inflammation in patients with peripheral arterial disease of the lower limbs.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Brachial Artery; C-Reactive Protein; Case-Control Studie | 2009 |
Dipyridamole enhances ischaemia-induced arteriogenesis through an endocrine nitrite/nitric oxide-dependent pathway.
Topics: Animals; Cell Division; Chronic Disease; Cyclic AMP-Dependent Protein Kinases; Dipyridamole; Dose-Re | 2010 |
[Therapy of vascular syndromes, particularly arteriolar, with pentaerythritol tetranitrate].
Topics: Nitrites; Pentaerythritol Tetranitrate; Peripheral Vascular Diseases; Syndrome; Vascular Diseases | 1952 |
[Therapy of peripheral circulatory disorders with tetraethylammonium nitrite].
Topics: Cardiovascular Diseases; Nitrites; Peripheral Vascular Diseases; Tetraethylammonium; Vascular Diseas | 1953 |
[Peripheral arterial circulatory disorders and therapy. I. Rheoangiographic registration of the effect of nitroglycerin preparations in healthy subjects].
Topics: Healthy Volunteers; Nitrites; Nitroglycerin; Peripheral Arterial Disease; Peripheral Vascular Diseas | 1956 |
[Treatment of coronary insufficiency, thromboangilitis & cerebral arteritis with intravenous sodium nitrate].
Topics: Arteritis; Brain; Coronary Disease; Humans; Nitrates; Nitrites; Peripheral Vascular Diseases; Thromb | 1957 |
Sustained-action peritrate in arterial insufficiency of the lower extremities.
Topics: Lower Extremity; Nitrites; Pentaerythritol Tetranitrate; Peripheral Vascular Diseases; Vascular Dise | 1958 |
[Variations of oscillometric indices of the extremities induced by nitroglycerin in healthy subjects and in arteriopathic patients].
Topics: Extremities; Healthy Volunteers; Humans; Nitrites; Nitroglycerin; Peripheral Vascular Diseases; Vasc | 1959 |
DRUGS USED IN PERIPHERAL VASCULAR DISEASES.
Topics: Deoxyribonuclease I; Dihydroergotoxine; Endopeptidases; Ergot Alkaloids; Ganglionic Blockers; Histam | 1963 |
[Treatment of spastic vascular diseases].
Topics: Alkaloids; Atropa belladonna; Barbiturates; Humans; Muscle Spasticity; Nitrites; Papaverine; Parasym | 1955 |
Peritrate in peripheral arterial diseases.
Topics: Nitrites; Pentaerythritol Tetranitrate; Peripheral Arterial Disease; Peripheral Vascular Diseases; V | 1952 |
Nitrite plasma levels in normolipemic and hypercholesterolemic patients with peripheral occlusive arteriopathy.
Topics: Aged; Arterial Occlusive Diseases; Female; Humans; Hypercholesterolemia; Leg; Lipids; Male; Middle A | 1999 |